Anesthesia

5
Pipeline Programs
6
Companies
14
Clinical Trials
2
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
1
3
Early DiscoveryClinical DevelopmentMarket

On Market (2)

Approved therapies currently available

U
ROCURONIUM BROMIDEApproved
rocuronium bromide
Unknown Company
injection2017
M&
ZEMURONApproved
rocuronium bromide
Merck & Co.
injection1994

Competitive Landscape

6 companies ranked by most advanced pipeline stage

M&
Merck & Co.RAHWAY, NJ
1 program
1
1
Rocuronium bromidePhase 35 trials
Active Trials
NCT05562999Completed100Est. Aug 2024
NCT03608436Completed178Est. Jun 2021
NCT03572413Completed100Est. Dec 2020
+2 more trials
E
EisaiChina - Liaoning
1 program
1
Fospropofol disodium, propofolPhase 41 trial
Active Trials
NCT01260142Completed36Est. Mar 2011
NeuroWave Systems
NeuroWave SystemsOH - Beachwood
1 program
1
Ketamine Injectable SolutionPhase 11 trial
Active Trials
NCT03009409CompletedEst. Oct 2018
Ambu
AmbuDenmark - Ballerup
2 programs
Ambu AuraGainN/A1 trial
Placement of laryngeal maskN/A1 trial
Active Trials
NCT02724956CompletedEst. Dec 2020
NCT04128527CompletedEst. Nov 2019
City Therapeutics
City TherapeuticsMA - Cambridge
2 programs
EEG-Guided Sedation in ERCP ProceduresN/A1 trial
Review of the Follow-up of Difficult Airway GuidelinesN/A1 trial
Active Trials
NCT06866886CompletedEst. Aug 2025
NCT06524141Active Not RecruitingEst. Jan 2025
Heidelberg Pharma
Heidelberg PharmaGermany - Ladenburg
1 program
Anesthesia depth monitorN/A1 trial
Active Trials
NCT02382445Completed138Est. May 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Merck & Co.Rocuronium bromide
Merck & Co.Rocuronium bromide
Merck & Co.Rocuronium bromide
EisaiFospropofol disodium, propofol
Merck & Co.Rocuronium bromide
Merck & Co.Rocuronium bromide
Merck & Co.Rocuronium bromide
Merck & Co.Rocuronium bromide
NeuroWave SystemsKetamine Injectable Solution
City TherapeuticsEEG-Guided Sedation in ERCP Procedures
City TherapeuticsReview of the Follow-up of Difficult Airway Guidelines
AmbuPlacement of laryngeal mask
AmbuAmbu AuraGain
Heidelberg PharmaAnesthesia depth monitor

Clinical Trials (14)

Total enrollment: 986 patients across 14 trials

NCT05562999Merck & Co.Rocuronium bromide

Impact of Deep Neuromuscular Blockade During Total Hip Replacement Surgery on Postoperative Recovery and Immune Function

Start: Nov 2022Est. completion: Aug 2024100 patients
Phase 4Completed
NCT03572413Merck & Co.Rocuronium bromide

The Effect of Low Pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery on Innate Immune Homeostasis.

Start: Oct 2018Est. completion: Dec 2020100 patients
Phase 4Completed
NCT03608436Merck & Co.Rocuronium bromide

The Effect of Low Pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery on Early Quality of Recovery

Start: Oct 2018Est. completion: Jun 2021178 patients
Phase 4Completed
NCT01260142EisaiFospropofol disodium, propofol

A PK/PD Study of Fospropofol Disodium Compared With Propofol Injectable Emulsion

Start: Nov 2010Est. completion: Mar 201136 patients
Phase 4Completed
NCT00124722Merck & Co.Rocuronium bromide

A Study to Compare Different Intubating Doses of Zemuron in Pediatric and Adolescent Subjects Under General Anesthesia

Start: Dec 2004Est. completion: Jul 2007207 patients
Phase 3Completed
NCT00124735Merck & Co.Rocuronium bromide

A Study to Determine the Dose Requirements of Rocuronium Bromide (Zemuron®) in Pediatric and Adolescent Subjects (21048)(COMPLETED)(P05797)

Start: Oct 2004Est. completion: Sep 2007149 patients
Phase 3Completed
NCT00984633Merck & Co.Rocuronium bromide

Study of Efficacy, Pharmacokinetics, and Safety of Bolus Maintenance Doses of Org 9426 (Study P05976)(COMPLETED)

Start: Jun 2003Est. completion: Dec 200340 patients
Phase 3Completed
NCT00988520Merck & Co.Rocuronium bromide

Study of Efficacy, Pharmacokinetics and Safety of Continuous Intravenous Infusion of Org 9426 (Study P05977)

Start: May 2003Est. completion: Sep 200338 patients
Phase 3Completed
NCT03009409NeuroWave SystemsKetamine Injectable Solution

The Effect of Low Dose Intra-operative Ketamine on Closed-loop Controlled General Anesthesia

Start: Mar 2018Est. completion: Oct 2018
Phase 1Completed
NCT06866886City TherapeuticsEEG-Guided Sedation in ERCP Procedures

EEG-Guided Sedation in ERCP Procedures

Start: Mar 2025Est. completion: Aug 2025
N/ACompleted
NCT06524141City TherapeuticsReview of the Follow-up of Difficult Airway Guidelines

Review of the Follow-up of Difficult Airway Guidelines

Start: Aug 2024Est. completion: Jan 2025
N/AActive Not Recruiting
NCT04128527AmbuPlacement of laryngeal mask

AuraOnce Performance Observation

Start: Oct 2019Est. completion: Nov 2019
N/ACompleted
NCT02724956AmbuAmbu AuraGain

Ambu AuraGain and Teleflex LMA Protector Fiberoptic Assessments in Elective Patients

Start: Nov 2017Est. completion: Dec 2020
N/ACompleted
NCT02382445Heidelberg PharmaAnesthesia depth monitor

Anesthesia Depth Increases the Degree of Postoperative Dementia, Delirium, and Cognitive Dysfunction

Start: Jan 2014Est. completion: May 2017138 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
6 companies competing in this space